Dignitana
1.15
SEK
-6.5 %
DIGN
First North Stockholm
Medical Equipment & Services
Health Care
3 following
-6.5%
+4.55%
-21.77%
-8.73%
-20.69%
-47.25%
-46.26%
-86.41%
-87.31%
-60.78%
dignitana.com/investor-relations
Dignitana is active in medical technology. The company's main focus is to develop, manufacture, and distribute medical aids that are primarily used as a scalp cooling system in chemotherapy treatment, where the purpose is to eliminate or greatly reduce hair loss. The company operates worldwide. Dignitana was founded in 2007 has its headquarters located in Lund.
Revenue
86.06M
EBIT %
-17.46 %
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
DIGN
Daily low / high price
1.14 / 1.21
SEK
Market cap
92.62M SEK
Turnover
17.57K SEK
Volume
15K
Latest videos
Financial calendar
Interim report
2024-11-21
Annual report
2025-02-20
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| Agartha AB | 29.8 % | 29.8 % |
| Swedbank Robur Microcap | 7.7 % | 7.7 % |
| Försäkringsbolaget Avanza Pension | 7.2 % | 7.2 % |
| UBS Financial Services INC | 5.2 % | 5.2 % |
| Handelsbanken Microcap Sverige | 4.8 % | 4.8 % |
| LQM Lundia AB | 3.3 % | 3.3 % |
| Magbaleo | 2.3 % | 2.3 % |
| Technovobis AB | 2.2 % | 2.2 % |
| FE Småbolag Sverige | 2.2 % | 2.2 % |
ShowingAll content types
Dignitana AB (publ) appoints Nomination Committee for Annual General Meeting 2025
Dignitana AB: University Hospital Schleswig-Holstein in Kiel, Germany selects DigniCap
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools